308
Participants
Start Date
October 31, 2004
Primary Completion Date
October 31, 2009
Study Completion Date
October 31, 2009
lacosamide
50mg or 100 mg tablets, up to 800 mg/day given twice daily (BID) throughout the trial
Birmingham
Mobile
Phoenix
Little Rock
Los Angeles
San Francisco
Englewood
Fairfield
Bradenton
Jacksonville
Maitland
St. Petersburg
Tallahassee
Tampa
Atlanta
Chicago
Springfield
Indianapolis
Wichita
Lexington
Louisville
Baltimore
Bethesda
Boston
Golden Valley
Saint Cloud
Saint Paul
Chesterfield
Somerset
Albuquerque
Buffalo
New York
Rochester
Syracuse
Asheville
Durham
Greenville
Winston-Salem
Cincinnati
Cleveland
Columbus
Toledo
Tulsa
Medford
Hershey
Philadelphia
Providence
Beaufort
Charleston
Nashville
Dallas
San Antonio
Charlottesville
Newport News
Norfolk
Richmond
Seattle
Morgantown
Marshfield
Milwaukee
UCB BIOSCIENCES, Inc.
INDUSTRY